Public/Investors

Person

Mentions

Relationships

Events

Documents

Relationship Network

Network Depth

Loading... nodes

Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

No relationships found for this entity.

No events found for this entity.

No documents found for this entity.

Total Received

$0.00

0 transactions

Total Paid

$200,000,000.00

1 transactions

Net Flow

-$200,000,000.00

1 total transactions

Date	Type	From	To	Amount	Description	Actions
N/A	Paid	Public/Investors	KUE	$200,000,000.00	Minimum gross proceeds required for the definit...	View

As Sender

As Recipient

Total

Conflicts of Interest Policies

From: BofA Merrill Lynch

To: Public/Investors

BofA Merrill Lynch Global Research policies relating to conflicts of interest are described at http://go.bofa.com/coi.

Website

N/A

Communication Source

Conflicts of Interest Policies

From: BofA Merrill Lynch

To: Public/Investors

A URL, http://go.bofa.com/coi, is provided where BofA Merrill Lynch Global Research policies relating to conflicts of interest are described.

Website

N/A

Communication Source

Physician survey on Praluent usage

From: Geoffrey Porges

To: Public/Investors

A survey of physicians found that they would use Praluent in 30% to 40% of patients who had already had heart attacks. Doctors also expressed a preference for Praluent in the survey.

Survey

N/A

Communication Source